CA1211440A - Carboxamido-derivatives of 5h-1,3,4-thiadiazolo ¬3, 2-a| pyrimidines and process for their preparation - Google Patents

Carboxamido-derivatives of 5h-1,3,4-thiadiazolo ¬3, 2-a| pyrimidines and process for their preparation

Info

Publication number
CA1211440A
CA1211440A CA000444151A CA444151A CA1211440A CA 1211440 A CA1211440 A CA 1211440A CA 000444151 A CA000444151 A CA 000444151A CA 444151 A CA444151 A CA 444151A CA 1211440 A CA1211440 A CA 1211440A
Authority
CA
Canada
Prior art keywords
pyridyl
oxo
carboxamide
group
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000444151A
Other languages
English (en)
French (fr)
Inventor
Gianfederico Doria
Carlo Passarotti
Ada Buttinoni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Farmitalia Carlo Erba SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB838329746A external-priority patent/GB8329746D0/en
Application filed by Farmitalia Carlo Erba SRL filed Critical Farmitalia Carlo Erba SRL
Application granted granted Critical
Publication of CA1211440A publication Critical patent/CA1211440A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/121,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • C07D285/1251,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • C07D285/135Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA000444151A 1982-12-23 1983-12-22 Carboxamido-derivatives of 5h-1,3,4-thiadiazolo ¬3, 2-a| pyrimidines and process for their preparation Expired CA1211440A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8236642 1982-12-23
GB8236642 1982-12-23
GB838329746A GB8329746D0 (en) 1983-11-08 1983-11-08 Carboxamido-derivatives
GB8329746 1983-11-08

Publications (1)

Publication Number Publication Date
CA1211440A true CA1211440A (en) 1986-09-16

Family

ID=26284768

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000444151A Expired CA1211440A (en) 1982-12-23 1983-12-22 Carboxamido-derivatives of 5h-1,3,4-thiadiazolo ¬3, 2-a| pyrimidines and process for their preparation

Country Status (15)

Country Link
US (1) US4522944A (enExample)
AT (1) AT385036B (enExample)
AU (1) AU558600B2 (enExample)
CA (1) CA1211440A (enExample)
CH (1) CH657136A5 (enExample)
DE (1) DE3346223A1 (enExample)
DK (1) DK593983A (enExample)
FI (1) FI834698A7 (enExample)
FR (1) FR2538392B1 (enExample)
GR (1) GR79479B (enExample)
IL (1) IL70522A (enExample)
IT (1) IT1194521B (enExample)
NL (1) NL8304340A (enExample)
SE (1) SE454698B (enExample)
SU (1) SU1297731A3 (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3702758A1 (de) * 1987-01-30 1988-09-29 Hoechst Ag Substituierte 3-phenyl-7h-thiazolo (3,2-b) (1,2,4) triazin-7-one, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung, sowie einige bei der herstellung der genannten verbindungen gebildete zwischenprodukte
JP5567349B2 (ja) 2007-03-12 2014-08-06 イントラ−セルラー・セラピーズ・インコーポレイテッド 置換ヘテロ環縮合ガンマ−カルボリンの合成
US11053245B2 (en) 2012-04-14 2021-07-06 Intra-Cellular Therapies, Inc. Methods
PL2968320T3 (pl) 2013-03-15 2021-05-17 Intra-Cellular Therapies, Inc. Związki organiczne
KR102373288B1 (ko) 2013-12-03 2022-03-10 인트라-셀룰라 써래피스, 인코퍼레이티드. 신규한 방법
BR112016023162B1 (pt) 2014-04-04 2022-11-29 Intra-Cellular Therapies, Inc Compostos orgânicos gama-carbolinas, composições farmacêuticas compreendendo os ditos compostos e uso dos mesmos no tratamento ou na profilaxia de transtornos de sistema nervoso central
JP2017509677A (ja) 2014-04-04 2017-04-06 イントラ−セルラー・セラピーズ・インコーポレイテッドIntra−Cellular Therapies, Inc. 有機化合物
IL296884B2 (en) 2016-01-26 2024-05-01 Intra Cellular Therapies Inc Condensed heterocyclic converted gamma carbonyls for use in the treatment of central nervous system disorders
JP2019510039A (ja) 2016-03-28 2019-04-11 イントラ−セルラー・セラピーズ・インコーポレイテッドIntra−Cellular Therapies, Inc. 新規組成物および方法
JP6997718B2 (ja) 2016-03-28 2022-01-18 イントラ-セルラー・セラピーズ・インコーポレイテッド 新規共結晶
WO2017172784A1 (en) 2016-03-28 2017-10-05 Intra-Cellular Therapies, Inc. Novel salts and crystals
WO2018071233A1 (en) 2016-10-12 2018-04-19 Intra-Cellular Therapies, Inc. Amorphous solid dispersions
WO2018126140A1 (en) 2016-12-29 2018-07-05 Intra-Cellular Therapies, Inc. Organic compounds
WO2018126143A1 (en) 2016-12-29 2018-07-05 Intra-Cellular Therapies, Inc. Organic compounds
CN116327770B (zh) 2017-03-24 2025-10-31 细胞内治疗公司 新组合物和方法
CA3071119A1 (en) 2017-07-26 2019-01-31 Intra-Cellular Therapies, Inc. Substituted heterocycle fused gamma-carbolines for treatment or prophylaxis of central nervous system disorders
AU2018307480B2 (en) 2017-07-26 2023-11-23 Intra-Cellular Therapies, Inc. Organic compounds
CA3094949A1 (en) 2018-03-23 2019-09-26 Intra-Cellular Therapies, Inc. Deuterated heterocycle fused gamma-carbolines
CA3102848A1 (en) 2018-06-06 2019-12-12 Intra-Cellular Therapies, Inc. Novel salts and crystals
MX2020013335A (es) 2018-06-08 2021-05-27 Intra Cellular Therapies Inc Metodos novedosos.
AU2019287460B2 (en) 2018-06-11 2024-02-15 Intra-Cellular Therapies, Inc. Substituted heterocycle fused gamma-carbolines synthesis
US12144808B2 (en) 2018-08-29 2024-11-19 Intra-Cellular Therapies, Inc. Compositions and methods
AU2019331490B2 (en) 2018-08-31 2025-04-24 Intra-Cellular Therapies, Inc. Novel methods
MX2021002322A (es) 2018-08-31 2021-04-28 Intra Cellular Therapies Inc Nuevos metodos.
CA3141223A1 (en) 2019-07-07 2021-01-14 Sharon Mates Novel methods
EP4072554A4 (en) 2019-12-11 2023-12-20 Intra-Cellular Therapies, Inc. ORGANIC COMPOUND
US12414948B2 (en) 2022-05-18 2025-09-16 Intra-Cellular Therapies, Inc. Methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5129981B2 (enExample) * 1973-07-17 1976-08-28
GB1568962A (en) * 1975-10-31 1980-06-11 Beecham Group Ltd Reparation and compositions containing them (heterocyclic-carbonylamino)pencillins methods for their p
JPS55115889A (en) * 1979-02-28 1980-09-06 Teijin Ltd 6-carbamoylthiazolo 3,2-a pyrimidine derivative and its preparation
JPS57142989A (en) * 1981-02-27 1982-09-03 Dai Ichi Seiyaku Co Ltd Thiazolopyrimidine derivative

Also Published As

Publication number Publication date
GR79479B (enExample) 1984-10-30
ATA438383A (de) 1987-07-15
IL70522A0 (en) 1984-03-30
FR2538392A1 (fr) 1984-06-29
CH657136A5 (de) 1986-08-15
DK593983A (da) 1984-06-24
SE454698B (sv) 1988-05-24
FR2538392B1 (fr) 1987-01-16
AU558600B2 (en) 1987-02-05
DK593983D0 (da) 1983-12-22
FI834698A7 (fi) 1984-06-24
AT385036B (de) 1988-02-10
FI834698A0 (fi) 1983-12-20
IL70522A (en) 1986-02-28
SE8307133L (sv) 1984-06-24
SE8307133D0 (sv) 1983-12-22
NL8304340A (nl) 1984-07-16
IT1194521B (it) 1988-09-22
AU2252583A (en) 1984-06-28
IT8324207A0 (it) 1983-12-16
US4522944A (en) 1985-06-11
SU1297731A3 (ru) 1987-03-15
DE3346223A1 (de) 1984-06-28

Similar Documents

Publication Publication Date Title
CA1211440A (en) Carboxamido-derivatives of 5h-1,3,4-thiadiazolo ¬3, 2-a| pyrimidines and process for their preparation
KR101443795B1 (ko) 항균성 조성물
AU2008334427B2 (en) Antibacterial condensed thiazoles
FI96857C (fi) Menetelmä valmistaa farmakologisesti käyttökelpoista tiatsoliyhdistettä
US8362037B2 (en) 2-aminopyridine analogs as glucokinase activators
EP1812440B1 (en) Pyrazolo[1,5-a]pyrimidines useful as inhibitors of protein kinases
CA1192546A (en) Substituted 1h-pyrazolo¬1,5-a|pyrimidines and process for their preparation
Segawa et al. Studies on pyridonecarboxylic acids. 1. Synthesis and antibacterial evaluation of 7-substituted-6-halo-4-oxo-4H-[1, 3] thiazeto [3, 2-a] quinoline-3-carboxylic acids
EP1986645A1 (en) Glucokinase activators
CA2137976A1 (en) Thienothiazine derivatives
AU2010336386A1 (en) Aminopyrimidine kinase inhibitors
EP2049503B1 (en) Quinazoline and pyridopyrimidine derivatives as p38 kinase inhibitors
EP2013204A2 (en) 2-aminopyridine analogs as glucokinase activators
WO2010135014A1 (en) Tri-cyclic pyrazolopyridine kinase inhibitors
US8481544B2 (en) Antibacterial compositions
WO2010096389A1 (en) Tetrahydrothiazolopyridine inhibitors of phosphatidylinositol 3-kinase
CA1218656A (en) Pyridothienotriazines
CA1211439A (en) Substituted 1,3,4-thiadiazolo¬3,2-a|pyrimidines and process for their preparation
GB2132200A (en) Carboxamido-derivatives of 5H-1,3,4-thiadiazolo[3,2-a]-pyrimidines and process for their preparation
AU2012200669B2 (en) Antibacterial compositions
GB2116971A (en) 1H-pyrazolo [1,5-a] pyrimidines
JPS59139389A (ja) 5H−1,3,4−チアジアゾロ〔3,2−a〕ピリミジンのカルボキサミド誘導体およびそれらの製法

Legal Events

Date Code Title Description
MKEX Expiry